1BSL01AE logo

Biotika a.s. Stock Price

BSSE:1BSL01AE Community·€7.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1BSL01AE Share Price Performance

€10.80
1.80 (20.00%)
€10.80
1.80 (20.00%)
Price €10.80

1BSL01AE Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

2 Risks
0 Rewards

Biotika a.s. Key Details

€18.2m

Revenue

€14.0m

Cost of Revenue

€4.1m

Gross Profit

€5.3m

Other Expenses

-€1.2m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-1.70
22.76%
-6.55%
13.5%
View Full Analysis

About 1BSL01AE

Founded
1953
Employees
165
CEO
n/a
WebsiteView website
www.biotika.sk

Biotika a.s., a biotechnology company, operates as a pharmaceutical manufacturing company in Slovakia and internationally. It offers active pharmaceutical ingredients (API), including Phenoxymethylpenicillin Potassium and Polymyxin B Sulfate. The company is also involved in the contract manufacture of APIs comprising Gramicidin S Hydrochlorid. In addition, it produces and sells cosmetic products; beverages, protein substances, and its derivatives; disinfectants and organic chemical; compost and organic fertilizer; medical devices; veterinary medicines; feed additives ; feed ingredients; freight road transportation services; rental services; rental of movable property; and retail and wholesale goods. Further, it provides waste water treatment and cooling water diversion services, as well as various services in the waste management sector; freight road transportation services; and rental services. Additionally, the company engages in the research and development of natural and technical sciences; and operation of railway track. Biotika a.s. was founded in 1953 and is headquartered in Slovenská Lupca, Slovakia.

Recent 1BSL01AE News & Updates

Analysis Article Oct 31

Investors Still Aren't Entirely Convinced By Biotika a.s.'s (BSSE:1BSL01AE) Revenues Despite 29% Price Jump

Biotika a.s. ( BSSE:1BSL01AE ) shareholders would be excited to see that the share price has had a great month, posting...

Recent updates

No updates

Biotika a.s. Competitors